nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—CYP3A4—Bexarotene—hematologic cancer	0.0363	0.0829	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Lomustine—hematologic cancer	0.0338	0.0771	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Busulfan—hematologic cancer	0.0338	0.0771	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Thiotepa—hematologic cancer	0.0301	0.0687	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Methoxsalen—hematologic cancer	0.0234	0.0534	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Bortezomib—hematologic cancer	0.0223	0.0508	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Daunorubicin—hematologic cancer	0.0213	0.0486	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Cytarabine—hematologic cancer	0.0188	0.0429	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Teniposide—hematologic cancer	0.0185	0.0422	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Ifosfamide—hematologic cancer	0.0171	0.039	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Imatinib—hematologic cancer	0.0163	0.0372	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Ruxolitinib—hematologic cancer	0.0154	0.0351	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Nilotinib—hematologic cancer	0.0148	0.0338	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Vinorelbine—hematologic cancer	0.0147	0.0335	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Triamcinolone—hematologic cancer	0.0134	0.0307	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Dasatinib—hematologic cancer	0.0131	0.0299	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Mitoxantrone—hematologic cancer	0.0129	0.0295	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Betamethasone—hematologic cancer	0.0115	0.0263	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Prednisolone—hematologic cancer	0.0114	0.026	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Prednisone—hematologic cancer	0.0107	0.0245	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Irinotecan—hematologic cancer	0.0102	0.0233	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Vinblastine—hematologic cancer	0.00905	0.0207	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Vincristine—hematologic cancer	0.0089	0.0203	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Etoposide—hematologic cancer	0.00816	0.0186	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Dexamethasone—hematologic cancer	0.00671	0.0153	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Doxorubicin—hematologic cancer	0.00556	0.0127	CbGbCtD
Isosorbide Mononitrate—GUCY1B3—hematopoietic system—hematologic cancer	0.00457	0.104	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—lung—hematologic cancer	0.00425	0.0968	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—testis—hematologic cancer	0.00401	0.0913	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—blood—hematologic cancer	0.00305	0.0695	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—blood—hematologic cancer	0.00303	0.069	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—bone marrow—hematologic cancer	0.00295	0.0673	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—bone marrow—hematologic cancer	0.00293	0.0668	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—lymph node—hematologic cancer	0.0029	0.0662	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—lung—hematologic cancer	0.00267	0.0609	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—lung—hematologic cancer	0.00265	0.0605	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—testis—hematologic cancer	0.00252	0.0575	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—testis—hematologic cancer	0.0025	0.0571	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—lymph node—hematologic cancer	0.00183	0.0417	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—lymph node—hematologic cancer	0.00182	0.0414	CbGeAlD
Isosorbide Mononitrate—CYP3A4—hematopoietic system—hematologic cancer	0.00132	0.03	CbGeAlD
Isosorbide Mononitrate—CYP3A4—blood—hematologic cancer	0.000871	0.0199	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—H3F3B—hematologic cancer	0.000348	0.00412	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SELL—hematologic cancer	0.000348	0.00412	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—FGR—hematologic cancer	0.000348	0.00412	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—H3F3B—hematologic cancer	0.000348	0.00412	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000341	0.00404	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL3RA—hematologic cancer	0.000339	0.00401	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ITGAL—hematologic cancer	0.000335	0.00397	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—MYB—hematologic cancer	0.000335	0.00397	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—MYB—hematologic cancer	0.000335	0.00397	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ITGAL—hematologic cancer	0.000335	0.00397	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—RAC2—hematologic cancer	0.000318	0.00377	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—RAC2—hematologic cancer	0.000318	0.00377	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—FGR—hematologic cancer	0.00031	0.00367	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—H3F3B—hematologic cancer	0.00031	0.00367	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000307	0.00364	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ITGAL—hematologic cancer	0.000299	0.00353	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—MYB—hematologic cancer	0.000299	0.00353	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—FOS—hematologic cancer	0.000292	0.00345	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CREB1—hematologic cancer	0.000291	0.00345	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SH2B3—hematologic cancer	0.000288	0.00341	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SH2B3—hematologic cancer	0.000288	0.00341	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—RAC2—hematologic cancer	0.000284	0.00336	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000276	0.00327	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SPARC—hematologic cancer	0.000275	0.00326	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SPARC—hematologic cancer	0.000275	0.00326	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—LCK—hematologic cancer	0.000266	0.00315	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—LCK—hematologic cancer	0.000266	0.00315	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—H3F3A—hematologic cancer	0.000261	0.00309	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—H3F3A—hematologic cancer	0.000261	0.00309	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—GATA3—hematologic cancer	0.000259	0.00306	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—GATA3—hematologic cancer	0.000259	0.00306	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HSPA5—hematologic cancer	0.000257	0.00305	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HSPA5—hematologic cancer	0.000257	0.00305	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SH2B3—hematologic cancer	0.000257	0.00304	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PRKCZ—hematologic cancer	0.000254	0.00301	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PRKCZ—hematologic cancer	0.000254	0.00301	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SPARC—hematologic cancer	0.000245	0.0029	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—LCK—hematologic cancer	0.000238	0.00281	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HDAC2—hematologic cancer	0.000237	0.0028	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HDAC2—hematologic cancer	0.000237	0.0028	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ITGA4—hematologic cancer	0.000234	0.00277	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ITGA4—hematologic cancer	0.000234	0.00277	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CD44—hematologic cancer	0.000234	0.00277	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CD44—hematologic cancer	0.000234	0.00277	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	0.000234	0.00277	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—H3F3A—hematologic cancer	0.000233	0.00276	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—GATA3—hematologic cancer	0.000231	0.00273	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HSPA5—hematologic cancer	0.00023	0.00272	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000229	0.00271	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL3—hematologic cancer	0.000228	0.0027	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL3—hematologic cancer	0.000228	0.0027	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IFNA1—hematologic cancer	0.000227	0.00268	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IFNA1—hematologic cancer	0.000227	0.00268	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PRKCZ—hematologic cancer	0.000226	0.00268	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PTPN1—hematologic cancer	0.000224	0.00265	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PTPN1—hematologic cancer	0.000224	0.00265	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—RASGRP1—hematologic cancer	0.000221	0.00261	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—RASGRP1—hematologic cancer	0.000221	0.00261	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SYK—hematologic cancer	0.00022	0.0026	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SYK—hematologic cancer	0.00022	0.0026	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000218	0.00258	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—hematologic cancer	0.000216	0.00256	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000215	0.00255	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HDAC2—hematologic cancer	0.000211	0.0025	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IFNA2—hematologic cancer	0.000211	0.0025	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IFNA2—hematologic cancer	0.000211	0.0025	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—JUN—hematologic cancer	0.000209	0.00248	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ITGA4—hematologic cancer	0.000209	0.00247	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CD44—hematologic cancer	0.000209	0.00247	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL3—hematologic cancer	0.000203	0.00241	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IFNA1—hematologic cancer	0.000202	0.00239	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PTPN1—hematologic cancer	0.0002	0.00237	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—GRB2—hematologic cancer	0.000198	0.00235	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—GRB2—hematologic cancer	0.000198	0.00235	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PDGFA—hematologic cancer	0.000198	0.00234	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PDGFA—hematologic cancer	0.000198	0.00234	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—RASGRP1—hematologic cancer	0.000197	0.00233	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SYK—hematologic cancer	0.000196	0.00232	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000193	0.00229	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ABL1—hematologic cancer	0.000191	0.00226	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ABL1—hematologic cancer	0.000191	0.00226	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IFNA2—hematologic cancer	0.000188	0.00222	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HGF—hematologic cancer	0.000179	0.00212	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HGF—hematologic cancer	0.000179	0.00212	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	0.000179	0.00212	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CSF2—hematologic cancer	0.000177	0.0021	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CSF2—hematologic cancer	0.000177	0.0021	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—GRB2—hematologic cancer	0.000177	0.00209	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PDGFA—hematologic cancer	0.000176	0.00209	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—JAK1—hematologic cancer	0.000171	0.00203	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PRKCG—hematologic cancer	0.000171	0.00203	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PRKCG—hematologic cancer	0.000171	0.00203	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—JAK1—hematologic cancer	0.000171	0.00203	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ABL1—hematologic cancer	0.00017	0.00201	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000168	0.00199	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL2RA—hematologic cancer	0.00016	0.00189	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HGF—hematologic cancer	0.00016	0.00189	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL2RA—hematologic cancer	0.00016	0.00189	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CSF2—hematologic cancer	0.000158	0.00187	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PDGFB—hematologic cancer	0.000154	0.00183	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PDGFB—hematologic cancer	0.000154	0.00183	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PRKCG—hematologic cancer	0.000153	0.00181	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—JAK1—hematologic cancer	0.000153	0.00181	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CDK2—hematologic cancer	0.00015	0.00177	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CDK2—hematologic cancer	0.00015	0.00177	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—MAPK14—hematologic cancer	0.000144	0.0017	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—MAPK14—hematologic cancer	0.000144	0.0017	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL2RA—hematologic cancer	0.000142	0.00169	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—FN1—hematologic cancer	0.000139	0.00165	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—FN1—hematologic cancer	0.000139	0.00165	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000139	0.00164	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PDGFB—hematologic cancer	0.000137	0.00163	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CDK2—hematologic cancer	0.000133	0.00158	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CG—hematologic cancer	0.000133	0.00158	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CG—hematologic cancer	0.000133	0.00158	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PTPN11—hematologic cancer	0.000131	0.00155	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PTPN11—hematologic cancer	0.000131	0.00155	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—MAPK14—hematologic cancer	0.000128	0.00151	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—hematologic cancer	0.000126	0.0015	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—FN1—hematologic cancer	0.000124	0.00147	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CREBBP—hematologic cancer	0.000123	0.00146	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CREBBP—hematologic cancer	0.000123	0.00146	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CG—hematologic cancer	0.000119	0.0014	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CD—hematologic cancer	0.000117	0.00139	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CD—hematologic cancer	0.000117	0.00139	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PTPN11—hematologic cancer	0.000117	0.00138	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000117	0.00138	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ALB—hematologic cancer	0.000116	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ALB—hematologic cancer	0.000116	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000111	0.00131	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3R1—hematologic cancer	0.000111	0.00131	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3R1—hematologic cancer	0.000111	0.00131	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.00011	0.0013	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CREBBP—hematologic cancer	0.00011	0.0013	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—JAK2—hematologic cancer	0.000107	0.00127	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—JAK2—hematologic cancer	0.000107	0.00127	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CD—hematologic cancer	0.000104	0.00123	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ALB—hematologic cancer	0.000103	0.00122	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CB—hematologic cancer	0.000102	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CB—hematologic cancer	0.000102	0.00121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3R1—hematologic cancer	9.85e-05	0.00117	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—JAK2—hematologic cancer	9.58e-05	0.00113	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL2—hematologic cancer	9.37e-05	0.00111	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL2—hematologic cancer	9.37e-05	0.00111	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	9.26e-05	0.0011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	9.13e-05	0.00108	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CB—hematologic cancer	9.09e-05	0.00108	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—EP300—hematologic cancer	8.41e-05	0.000995	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—EP300—hematologic cancer	8.41e-05	0.000995	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL2—hematologic cancer	8.35e-05	0.000988	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SRC—hematologic cancer	8.18e-05	0.000968	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SRC—hematologic cancer	8.18e-05	0.000968	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—VEGFA—hematologic cancer	7.96e-05	0.000942	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—VEGFA—hematologic cancer	7.96e-05	0.000942	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—NRAS—hematologic cancer	7.87e-05	0.000931	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—NRAS—hematologic cancer	7.87e-05	0.000931	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—MAPK3—hematologic cancer	7.53e-05	0.000892	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—MAPK3—hematologic cancer	7.53e-05	0.000892	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—EP300—hematologic cancer	7.49e-05	0.000887	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TGFB1—hematologic cancer	7.31e-05	0.000865	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TGFB1—hematologic cancer	7.31e-05	0.000865	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SRC—hematologic cancer	7.29e-05	0.000862	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—VEGFA—hematologic cancer	7.1e-05	0.00084	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—NRAS—hematologic cancer	7.01e-05	0.00083	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—KRAS—hematologic cancer	6.77e-05	0.000801	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—KRAS—hematologic cancer	6.77e-05	0.000801	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—MAPK3—hematologic cancer	6.71e-05	0.000795	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TGFB1—hematologic cancer	6.51e-05	0.000771	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CA—hematologic cancer	6.22e-05	0.000736	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CA—hematologic cancer	6.22e-05	0.000736	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—KRAS—hematologic cancer	6.03e-05	0.000714	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TP53—hematologic cancer	6.02e-05	0.000712	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TP53—hematologic cancer	6.02e-05	0.000712	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	5.96e-05	0.000706	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	5.88e-05	0.000696	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HRAS—hematologic cancer	5.75e-05	0.000681	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HRAS—hematologic cancer	5.75e-05	0.000681	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	5.61e-05	0.000664	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CA—hematologic cancer	5.54e-05	0.000656	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	5.53e-05	0.000655	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TP53—hematologic cancer	5.36e-05	0.000635	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HRAS—hematologic cancer	5.13e-05	0.000607	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—AKT1—hematologic cancer	5.08e-05	0.000601	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—AKT1—hematologic cancer	5.08e-05	0.000601	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	4.95e-05	0.000586	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—MTR—hematologic cancer	4.86e-05	0.000575	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	4.63e-05	0.000547	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—AKT1—hematologic cancer	4.53e-05	0.000536	CbGpPWpGaD
Isosorbide Mononitrate—Nervous system disorder—Prednisone—hematologic cancer	3.32e-05	7.66e-05	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Prednisone—hematologic cancer	3.31e-05	7.62e-05	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Prednisone—hematologic cancer	3.29e-05	7.59e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Gemcitabine—hematologic cancer	3.29e-05	7.58e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Cisplatin—hematologic cancer	3.28e-05	7.56e-05	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Prednisone—hematologic cancer	3.27e-05	7.55e-05	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Methotrexate—hematologic cancer	3.27e-05	7.54e-05	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Epirubicin—hematologic cancer	3.27e-05	7.53e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Cisplatin—hematologic cancer	3.25e-05	7.5e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Cisplatin—hematologic cancer	3.25e-05	7.49e-05	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Epirubicin—hematologic cancer	3.25e-05	7.49e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Etoposide—hematologic cancer	3.23e-05	7.46e-05	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Prednisone—hematologic cancer	3.23e-05	7.45e-05	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Methotrexate—hematologic cancer	3.22e-05	7.42e-05	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Doxorubicin—hematologic cancer	3.22e-05	7.42e-05	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Methotrexate—hematologic cancer	3.21e-05	7.39e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.21e-05	0.000379	CbGpPWpGaD
Isosorbide Mononitrate—Feeling abnormal—Betamethasone—hematologic cancer	3.21e-05	7.39e-05	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Dexamethasone—hematologic cancer	3.21e-05	7.39e-05	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Doxorubicin—hematologic cancer	3.2e-05	7.38e-05	CcSEcCtD
Isosorbide Mononitrate—Flushing—Doxorubicin—hematologic cancer	3.2e-05	7.38e-05	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Epirubicin—hematologic cancer	3.2e-05	7.38e-05	CcSEcCtD
Isosorbide Mononitrate—Tension—Epirubicin—hematologic cancer	3.19e-05	7.35e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.18e-05	7.33e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Betamethasone—hematologic cancer	3.18e-05	7.33e-05	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Epirubicin—hematologic cancer	3.18e-05	7.33e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.16e-05	0.000374	CbGpPWpGaD
Isosorbide Mononitrate—Hypersensitivity—Triamcinolone—hematologic cancer	3.16e-05	7.28e-05	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Epirubicin—hematologic cancer	3.15e-05	7.27e-05	CcSEcCtD
Isosorbide Mononitrate—Back pain—Epirubicin—hematologic cancer	3.14e-05	7.24e-05	CcSEcCtD
Isosorbide Mononitrate—Malaise—Methotrexate—hematologic cancer	3.13e-05	7.21e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Etoposide—hematologic cancer	3.13e-05	7.21e-05	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Epirubicin—hematologic cancer	3.12e-05	7.2e-05	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Methotrexate—hematologic cancer	3.12e-05	7.19e-05	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Methotrexate—hematologic cancer	3.1e-05	7.16e-05	CcSEcCtD
Isosorbide Mononitrate—Chills—Doxorubicin—hematologic cancer	3.1e-05	7.14e-05	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.09e-05	7.12e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Prednisolone—hematologic cancer	3.08e-05	7.11e-05	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Doxorubicin—hematologic cancer	3.08e-05	7.11e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Triamcinolone—hematologic cancer	3.08e-05	7.09e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Dexamethasone—hematologic cancer	3.07e-05	7.09e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Betamethasone—hematologic cancer	3.07e-05	7.09e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Dexamethasone—hematologic cancer	3.07e-05	7.09e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Betamethasone—hematologic cancer	3.07e-05	7.09e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Cisplatin—hematologic cancer	3.06e-05	7.07e-05	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Prednisone—hematologic cancer	3.06e-05	7.06e-05	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Epirubicin—hematologic cancer	3.06e-05	7.05e-05	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Prednisone—hematologic cancer	3.04e-05	7.01e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Triamcinolone—hematologic cancer	3.03e-05	6.99e-05	CcSEcCtD
Isosorbide Mononitrate—Cough—Methotrexate—hematologic cancer	3.03e-05	6.98e-05	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Doxorubicin—hematologic cancer	3.02e-05	6.97e-05	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Epirubicin—hematologic cancer	3.01e-05	6.95e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Etoposide—hematologic cancer	3e-05	6.93e-05	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Doxorubicin—hematologic cancer	3e-05	6.93e-05	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Epirubicin—hematologic cancer	3e-05	6.92e-05	CcSEcCtD
Isosorbide Mononitrate—Agitation—Epirubicin—hematologic cancer	2.98e-05	6.88e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Prednisone—hematologic cancer	2.98e-05	6.88e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Etoposide—hematologic cancer	2.98e-05	6.87e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Etoposide—hematologic cancer	2.98e-05	6.87e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Etoposide—hematologic cancer	2.96e-05	6.83e-05	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Doxorubicin—hematologic cancer	2.96e-05	6.82e-05	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Methotrexate—hematologic cancer	2.95e-05	6.81e-05	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Methotrexate—hematologic cancer	2.95e-05	6.81e-05	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Methotrexate—hematologic cancer	2.95e-05	6.81e-05	CcSEcCtD
Isosorbide Mononitrate—Tension—Doxorubicin—hematologic cancer	2.95e-05	6.8e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.95e-05	0.000349	CbGpPWpGaD
Isosorbide Mononitrate—Decreased appetite—Prednisone—hematologic cancer	2.94e-05	6.79e-05	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Doxorubicin—hematologic cancer	2.94e-05	6.78e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Prednisolone—hematologic cancer	2.94e-05	6.78e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Prednisolone—hematologic cancer	2.94e-05	6.77e-05	CcSEcCtD
Isosorbide Mononitrate—Malaise—Epirubicin—hematologic cancer	2.93e-05	6.75e-05	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Prednisone—hematologic cancer	2.92e-05	6.73e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Prednisolone—hematologic cancer	2.92e-05	6.73e-05	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Methotrexate—hematologic cancer	2.92e-05	6.73e-05	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Doxorubicin—hematologic cancer	2.92e-05	6.73e-05	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Epirubicin—hematologic cancer	2.92e-05	6.73e-05	CcSEcCtD
Isosorbide Mononitrate—Syncope—Epirubicin—hematologic cancer	2.91e-05	6.71e-05	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Epirubicin—hematologic cancer	2.91e-05	6.7e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.91e-05	0.000344	CbGpPWpGaD
Isosorbide Mononitrate—Back pain—Doxorubicin—hematologic cancer	2.91e-05	6.7e-05	CcSEcCtD
Isosorbide Mononitrate—Constipation—Prednisone—hematologic cancer	2.9e-05	6.68e-05	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Doxorubicin—hematologic cancer	2.89e-05	6.66e-05	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Epirubicin—hematologic cancer	2.87e-05	6.61e-05	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Methotrexate—hematologic cancer	2.85e-05	6.58e-05	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Epirubicin—hematologic cancer	2.85e-05	6.58e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Triamcinolone—hematologic cancer	2.83e-05	6.54e-05	CcSEcCtD
Isosorbide Mononitrate—Cough—Epirubicin—hematologic cancer	2.83e-05	6.53e-05	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Doxorubicin—hematologic cancer	2.83e-05	6.53e-05	CcSEcCtD
Isosorbide Mononitrate—Infection—Methotrexate—hematologic cancer	2.81e-05	6.49e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Etoposide—hematologic cancer	2.81e-05	6.47e-05	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Epirubicin—hematologic cancer	2.8e-05	6.46e-05	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Prednisone—hematologic cancer	2.79e-05	6.44e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Betamethasone—hematologic cancer	2.79e-05	6.44e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Dexamethasone—hematologic cancer	2.79e-05	6.44e-05	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Doxorubicin—hematologic cancer	2.79e-05	6.43e-05	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Methotrexate—hematologic cancer	2.78e-05	6.4e-05	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Doxorubicin—hematologic cancer	2.78e-05	6.4e-05	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Methotrexate—hematologic cancer	2.77e-05	6.39e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Prednisone—hematologic cancer	2.77e-05	6.39e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Prednisolone—hematologic cancer	2.77e-05	6.38e-05	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Epirubicin—hematologic cancer	2.76e-05	6.37e-05	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Epirubicin—hematologic cancer	2.76e-05	6.37e-05	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Epirubicin—hematologic cancer	2.76e-05	6.37e-05	CcSEcCtD
Isosorbide Mononitrate—Agitation—Doxorubicin—hematologic cancer	2.76e-05	6.36e-05	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Epirubicin—hematologic cancer	2.75e-05	6.35e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Dexamethasone—hematologic cancer	2.75e-05	6.35e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Betamethasone—hematologic cancer	2.75e-05	6.35e-05	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Methotrexate—hematologic cancer	2.75e-05	6.34e-05	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Methotrexate—hematologic cancer	2.74e-05	6.31e-05	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Epirubicin—hematologic cancer	2.73e-05	6.3e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Triamcinolone—hematologic cancer	2.73e-05	6.29e-05	CcSEcCtD
Isosorbide Mononitrate—Malaise—Doxorubicin—hematologic cancer	2.71e-05	6.25e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Triamcinolone—hematologic cancer	2.7e-05	6.23e-05	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Epirubicin—hematologic cancer	2.7e-05	6.23e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Triamcinolone—hematologic cancer	2.7e-05	6.23e-05	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Doxorubicin—hematologic cancer	2.7e-05	6.22e-05	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Methotrexate—hematologic cancer	2.7e-05	6.22e-05	CcSEcCtD
Isosorbide Mononitrate—Syncope—Doxorubicin—hematologic cancer	2.69e-05	6.21e-05	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Doxorubicin—hematologic cancer	2.69e-05	6.2e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Triamcinolone—hematologic cancer	2.69e-05	6.19e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Prednisone—hematologic cancer	2.68e-05	6.17e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Prednisone—hematologic cancer	2.68e-05	6.17e-05	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Epirubicin—hematologic cancer	2.67e-05	6.16e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Betamethasone—hematologic cancer	2.66e-05	6.14e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Dexamethasone—hematologic cancer	2.66e-05	6.14e-05	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Doxorubicin—hematologic cancer	2.65e-05	6.12e-05	CcSEcCtD
Isosorbide Mononitrate—Oedema—Epirubicin—hematologic cancer	2.65e-05	6.11e-05	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Methotrexate—hematologic cancer	2.65e-05	6.1e-05	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Doxorubicin—hematologic cancer	2.64e-05	6.09e-05	CcSEcCtD
Isosorbide Mononitrate—Infection—Epirubicin—hematologic cancer	2.63e-05	6.07e-05	CcSEcCtD
Isosorbide Mononitrate—Cough—Doxorubicin—hematologic cancer	2.62e-05	6.04e-05	CcSEcCtD
Isosorbide Mononitrate—Shock—Epirubicin—hematologic cancer	2.61e-05	6.01e-05	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Epirubicin—hematologic cancer	2.6e-05	5.99e-05	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Epirubicin—hematologic cancer	2.59e-05	5.98e-05	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Doxorubicin—hematologic cancer	2.59e-05	5.98e-05	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Epirubicin—hematologic cancer	2.59e-05	5.96e-05	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.58e-05	5.95e-05	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Epirubicin—hematologic cancer	2.57e-05	5.93e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Betamethasone—hematologic cancer	2.57e-05	5.93e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Dexamethasone—hematologic cancer	2.57e-05	5.93e-05	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Epirubicin—hematologic cancer	2.56e-05	5.91e-05	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Methotrexate—hematologic cancer	2.56e-05	5.9e-05	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Doxorubicin—hematologic cancer	2.56e-05	5.9e-05	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Doxorubicin—hematologic cancer	2.56e-05	5.9e-05	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Doxorubicin—hematologic cancer	2.56e-05	5.9e-05	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Doxorubicin—hematologic cancer	2.55e-05	5.88e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Triamcinolone—hematologic cancer	2.55e-05	5.87e-05	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Methotrexate—hematologic cancer	2.54e-05	5.86e-05	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Doxorubicin—hematologic cancer	2.53e-05	5.83e-05	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Epirubicin—hematologic cancer	2.53e-05	5.82e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Methotrexate—hematologic cancer	2.52e-05	5.82e-05	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Methotrexate—hematologic cancer	2.52e-05	5.8e-05	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Doxorubicin—hematologic cancer	2.5e-05	5.77e-05	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Prednisone—hematologic cancer	2.5e-05	5.75e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Methotrexate—hematologic cancer	2.49e-05	5.75e-05	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Epirubicin—hematologic cancer	2.48e-05	5.71e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Dexamethasone—hematologic cancer	2.47e-05	5.7e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Betamethasone—hematologic cancer	2.47e-05	5.7e-05	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Doxorubicin—hematologic cancer	2.47e-05	5.7e-05	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Methotrexate—hematologic cancer	2.46e-05	5.67e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—FTCD—hematologic cancer	2.46e-05	0.000291	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GMPS—hematologic cancer	2.46e-05	0.000291	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PHYH—hematologic cancer	2.46e-05	0.000291	CbGpPWpGaD
Isosorbide Mononitrate—Rash—Betamethasone—hematologic cancer	2.45e-05	5.66e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Dexamethasone—hematologic cancer	2.45e-05	5.66e-05	CcSEcCtD
Isosorbide Mononitrate—Oedema—Doxorubicin—hematologic cancer	2.45e-05	5.65e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Dexamethasone—hematologic cancer	2.45e-05	5.65e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Betamethasone—hematologic cancer	2.45e-05	5.65e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.44e-05	5.64e-05	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Methotrexate—hematologic cancer	2.44e-05	5.63e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Dexamethasone—hematologic cancer	2.44e-05	5.62e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Betamethasone—hematologic cancer	2.44e-05	5.62e-05	CcSEcCtD
Isosorbide Mononitrate—Infection—Doxorubicin—hematologic cancer	2.44e-05	5.62e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Prednisone—hematologic cancer	2.43e-05	5.6e-05	CcSEcCtD
Isosorbide Mononitrate—Pain—Methotrexate—hematologic cancer	2.42e-05	5.58e-05	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.41e-05	5.57e-05	CcSEcCtD
Isosorbide Mononitrate—Shock—Doxorubicin—hematologic cancer	2.41e-05	5.56e-05	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Doxorubicin—hematologic cancer	2.4e-05	5.54e-05	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Doxorubicin—hematologic cancer	2.4e-05	5.53e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Prednisone—hematologic cancer	2.4e-05	5.53e-05	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Epirubicin—hematologic cancer	2.4e-05	5.53e-05	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Doxorubicin—hematologic cancer	2.39e-05	5.52e-05	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Doxorubicin—hematologic cancer	2.38e-05	5.49e-05	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Epirubicin—hematologic cancer	2.38e-05	5.49e-05	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Doxorubicin—hematologic cancer	2.37e-05	5.46e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Epirubicin—hematologic cancer	2.36e-05	5.45e-05	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Epirubicin—hematologic cancer	2.36e-05	5.43e-05	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Doxorubicin—hematologic cancer	2.34e-05	5.39e-05	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Methotrexate—hematologic cancer	2.33e-05	5.38e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Epirubicin—hematologic cancer	2.33e-05	5.38e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Prednisone—hematologic cancer	2.32e-05	5.34e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Methotrexate—hematologic cancer	2.31e-05	5.34e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Dexamethasone—hematologic cancer	2.31e-05	5.33e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Betamethasone—hematologic cancer	2.31e-05	5.33e-05	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Epirubicin—hematologic cancer	2.3e-05	5.31e-05	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Doxorubicin—hematologic cancer	2.29e-05	5.28e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.29e-05	5.27e-05	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Epirubicin—hematologic cancer	2.28e-05	5.27e-05	CcSEcCtD
Isosorbide Mononitrate—Pain—Epirubicin—hematologic cancer	2.27e-05	5.22e-05	CcSEcCtD
Isosorbide Mononitrate—Constipation—Epirubicin—hematologic cancer	2.27e-05	5.22e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.25e-05	0.000266	CbGpPWpGaD
Isosorbide Mononitrate—Dizziness—Prednisone—hematologic cancer	2.24e-05	5.17e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Methotrexate—hematologic cancer	2.24e-05	5.16e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Methotrexate—hematologic cancer	2.24e-05	5.16e-05	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.23e-05	5.15e-05	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Doxorubicin—hematologic cancer	2.22e-05	5.11e-05	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Doxorubicin—hematologic cancer	2.2e-05	5.08e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Doxorubicin—hematologic cancer	2.19e-05	5.04e-05	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Epirubicin—hematologic cancer	2.18e-05	5.03e-05	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Doxorubicin—hematologic cancer	2.18e-05	5.03e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Epirubicin—hematologic cancer	2.17e-05	5e-05	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Doxorubicin—hematologic cancer	2.16e-05	4.98e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Prednisone—hematologic cancer	2.15e-05	4.97e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Prednisone—hematologic cancer	2.14e-05	4.93e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Prednisone—hematologic cancer	2.13e-05	4.92e-05	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Doxorubicin—hematologic cancer	2.13e-05	4.91e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Prednisone—hematologic cancer	2.12e-05	4.89e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.12e-05	4.88e-05	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Doxorubicin—hematologic cancer	2.11e-05	4.87e-05	CcSEcCtD
Isosorbide Mononitrate—Pain—Doxorubicin—hematologic cancer	2.1e-05	4.83e-05	CcSEcCtD
Isosorbide Mononitrate—Constipation—Doxorubicin—hematologic cancer	2.1e-05	4.83e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Epirubicin—hematologic cancer	2.09e-05	4.83e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Epirubicin—hematologic cancer	2.09e-05	4.83e-05	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Methotrexate—hematologic cancer	2.09e-05	4.81e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Methotrexate—hematologic cancer	2.03e-05	4.68e-05	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Doxorubicin—hematologic cancer	2.02e-05	4.66e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Prednisone—hematologic cancer	2.01e-05	4.64e-05	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Doxorubicin—hematologic cancer	2e-05	4.62e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Methotrexate—hematologic cancer	2e-05	4.62e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—ASNS—hematologic cancer	1.96e-05	0.000232	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—DCK—hematologic cancer	1.96e-05	0.000232	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.96e-05	0.000232	CbGpPWpGaD
Isosorbide Mononitrate—Hypersensitivity—Epirubicin—hematologic cancer	1.95e-05	4.5e-05	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Doxorubicin—hematologic cancer	1.94e-05	4.47e-05	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Doxorubicin—hematologic cancer	1.94e-05	4.47e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Methotrexate—hematologic cancer	1.94e-05	4.47e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Epirubicin—hematologic cancer	1.9e-05	4.38e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Epirubicin—hematologic cancer	1.87e-05	4.32e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Methotrexate—hematologic cancer	1.87e-05	4.32e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—HDC—hematologic cancer	1.86e-05	0.00022	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Epirubicin—hematologic cancer	1.81e-05	4.18e-05	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Doxorubicin—hematologic cancer	1.81e-05	4.16e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Methotrexate—hematologic cancer	1.8e-05	4.15e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Methotrexate—hematologic cancer	1.78e-05	4.12e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Methotrexate—hematologic cancer	1.78e-05	4.11e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Methotrexate—hematologic cancer	1.77e-05	4.09e-05	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Doxorubicin—hematologic cancer	1.76e-05	4.06e-05	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Epirubicin—hematologic cancer	1.75e-05	4.04e-05	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Doxorubicin—hematologic cancer	1.73e-05	4e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—CDA—hematologic cancer	1.7e-05	0.000202	CbGpPWpGaD
Isosorbide Mononitrate—Vomiting—Epirubicin—hematologic cancer	1.68e-05	3.88e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Methotrexate—hematologic cancer	1.68e-05	3.88e-05	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Doxorubicin—hematologic cancer	1.68e-05	3.87e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Epirubicin—hematologic cancer	1.67e-05	3.85e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Epirubicin—hematologic cancer	1.67e-05	3.85e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Epirubicin—hematologic cancer	1.66e-05	3.83e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—PC—hematologic cancer	1.64e-05	0.000194	CbGpPWpGaD
Isosorbide Mononitrate—Dizziness—Doxorubicin—hematologic cancer	1.62e-05	3.74e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.58e-05	0.000187	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GBA—hematologic cancer	1.58e-05	0.000187	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Epirubicin—hematologic cancer	1.57e-05	3.63e-05	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Doxorubicin—hematologic cancer	1.56e-05	3.59e-05	CcSEcCtD
Isosorbide Mononitrate—Rash—Doxorubicin—hematologic cancer	1.55e-05	3.56e-05	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Doxorubicin—hematologic cancer	1.54e-05	3.56e-05	CcSEcCtD
Isosorbide Mononitrate—Headache—Doxorubicin—hematologic cancer	1.54e-05	3.54e-05	CcSEcCtD
Isosorbide Mononitrate—Nausea—Doxorubicin—hematologic cancer	1.46e-05	3.36e-05	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTAP—hematologic cancer	1.45e-05	0.000171	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—FHL2—hematologic cancer	1.29e-05	0.000153	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AGRN—hematologic cancer	1.27e-05	0.00015	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—IDH2—hematologic cancer	1.2e-05	0.000142	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HMMR—hematologic cancer	1.2e-05	0.000142	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.13e-05	0.000133	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CA9—hematologic cancer	1.1e-05	0.00013	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ACP5—hematologic cancer	1.1e-05	0.00013	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.08e-05	0.000128	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—IDH1—hematologic cancer	1.03e-05	0.000122	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.02e-05	0.000121	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TXN—hematologic cancer	1.02e-05	0.000121	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.02e-05	0.000121	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.98e-06	0.000118	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.59e-06	0.000114	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.33e-06	0.00011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.33e-06	0.00011	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.09e-06	0.000108	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NUP98—hematologic cancer	8.81e-06	0.000104	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.55e-06	0.000101	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.55e-06	0.000101	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NUP214—hematologic cancer	8.49e-06	0.0001	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTR—hematologic cancer	8.32e-06	9.84e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.32e-06	9.84e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ENO2—hematologic cancer	8.15e-06	9.65e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.91e-06	9.36e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SDC1—hematologic cancer	7.73e-06	9.15e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CD44—hematologic cancer	6.57e-06	7.78e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NQO1—hematologic cancer	6.57e-06	7.78e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYCS—hematologic cancer	6.22e-06	7.36e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.18e-06	7.31e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.48e-06	6.49e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.19e-06	6.14e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.04e-06	5.96e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.04e-06	5.96e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.45e-06	5.27e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.74e-06	4.43e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.47e-06	4.1e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.29e-06	3.89e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALB—hematologic cancer	3.25e-06	3.84e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.11e-06	3.68e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.87e-06	3.39e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTEN—hematologic cancer	2.48e-06	2.93e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—EP300—hematologic cancer	2.36e-06	2.8e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.75e-06	2.07e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AKT1—hematologic cancer	1.43e-06	1.69e-05	CbGpPWpGaD
